See the DrugPatentWatch profile for ozempic

Ozempic (generic name: semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to improve glycemic control in adults with type 2 diabetes. It is administered once daily via subcutaneous injection.

According to the drug's prescribing information, Ozempic's effect on blood sugar lasts for approximately 24 hours. It works by mimicking the functions of natural hormones in the body to regulate blood sugar levels. Specifically, Ozempic stimulates the pancreas to produce insulin, decreases the release of glucagon (a hormone that raises blood sugar levels), and slows down digestion, which helps to prevent spikes in blood sugar after meals.

It is important to note that the duration of Ozempic's effect on blood sugar may vary depending on individual factors, such as the dose taken, the timing of injections, and the presence of other medical conditions or medications that may affect blood sugar levels.

In summary, based on the available information, Ozempic's effect on blood sugar lasts for approximately 24 hours, but individual factors may affect the duration of its effect.

Sources:

1. Novo Nordisk. (2021). Ozempic (semaglutide) injection, for subcutaneous use. Prescribing information. <https://www.novo-pi.com/ozempic.pdf>
2. DrugPatentWatch. (2021). Ozempic (semaglutide) drug patent insights. <https://www.drugpatentwatch.com/drugs/ozempic>